The biggest opportunities in the investment world today
Day 4 of Livewire’s 12 days of Christmas brings insights from four experts.
On the fourth day of Christmas, Livewire gave to me…
Four generous gurus sharing great insights into their fields
We invited some of our top contributors to share insights into their areas of expertise. Think the most exciting biotech innovations, the biggest trends in thematic ETFs, the nuclear renaissance and what's next for the Magnificent Seven.
Today, you can read insights from:
- Hashan De Silva, KP Rx
- Sally Fang, Swell Asset Management
- Sarah Lau, Resolution Capital
- Billy Leung, Global X ETFs
Read the insights:
Equities
There's more to Australian biotech than just CSL: the opportunities to watch
View
Equities
Are the Magnificent Seven doomed to underperform in 2025?
View
Equities
The nuclear renaissance is here: where to invest
View
Funds
3 portfolio themes to consider for growth investors in 2025
View
Missed the past few days?
Visit the series page for all the fun.
Don’t forget our Christmas competition, download your competition card today:
Investment Theme
The 12 days of Livewire Christmas are here – and you can be a winner!
View
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Livewire Exclusive brings you exclusive content from a wide range of leading fund managers and investment professionals.
........
Livewire gives readers access to information and educational content provided by financial services professionals and companies (“Livewire Contributors”). Livewire does not operate under an Australian financial services licence and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any advice given. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs. Before making a decision please consider these and any relevant Product Disclosure Statement. Livewire has commercial relationships with some Livewire Contributors.
3 topics
4 contributors mentioned
Comments
Comments
Sign In or Join Free to comment
most popular
Equities
The 10 most-tipped ASX income stocks for 2025
Livewire Markets
Equities
Global growth and shorting opportunities abound
Plato Investment Management